Transcode Therapeutics Share Price (NASDAQ: RNAZ)
$10.12
▲
0.07
(0.7%)
Live
Last updated on
Check the interactive Transcode Therapeutics Stock chart to analyse performance
Transcode Therapeutics stock performance
as on August 28, 2025 at 11:34 pm IST
- Today's Low:$10.12Today's High:$10.14
0.0%
Downside
Day's Volatility :0.2%
Upside
0.2%
- 52 Weeks Low:$6.1552 Weeks High:$739.20
39.25%
Downside
52 Weeks Volatility :99.17%
Upside
98.63%
Transcode Therapeutics Stock Returns
Transcode Therapeutics Inc Key Stats
Check Transcode Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Transcode Therapeutics Stock including INR - Dollar returns
The Transcode Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Transcode Therapeutics investment value today
Current value as on today
₹8,164
Returns
Returns from Transcode Therapeutics Stock
Dollar Returns*
₹4,360 (+4.36%)
Indian investors sentiment towards Transcode Therapeutics Stock
Global Institutional Holdings in Transcode Therapeutics Inc
Name
Holdings %
Anson Funds Management LP
6.26%
Goldman Sachs Group Inc
3.36%
UBS Group AG
1.13%
Sabby Management LLC
0.98%
Corsair Capital Management LLC
0.17%
Ground Swell Capital, LLC
0.06%
Analyst Recommendation on Transcode Therapeutics Stock
Buy
85%Buy
14%Hold
0%Sell
Based on 7 Wall street analysts offering stock ratings for Transcode Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Transcode Therapeutics Share Price Target
What analysts predicted
Downside of 1.19%
Target:
$10.00
Current:
$10.12
Transcode Therapeutics share price target is $10.00, a slight Downside of 1.19% compared to current price of $10.12 as per analysts' prediction.
Transcode Therapeutics Stock Insights
Price Movement
In the last 1 month, RNAZ stock has moved down by -27.6%RNAZ vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 158.0%RNAZ vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 215.3%
Transcode Therapeutics Technicals Summary
Sell
Neutral
Buy
Transcode Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Transcode Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -14.54% | -85.76% | -96.22% | -100.0% | -100.0% |
 | 5.16% | -16.48% | -51.06% | -0.98% | -5.32% |
 | -1.83% | 7.82% | 51.46% | 79.4% | 24.25% |
 | -16.94% | -18.0% | -20.55% | 38.17% | 39.4% |
 | 37.4% | 91.56% | 61.8% | 117.28% | 242.42% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.0 | NA | NA | 0.0 | -6.59 | -1.4 | NA | 7.37 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.58 | 27.58 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $8.6M | -100.0% | 0.0 | 0.0% |
| Buy | $62.5B | -5.32% | 14.86 | 31.37% |
| NA | $37.7B | 24.25% | NA | -3.89% |
| Buy | $99.3B | 39.4% | 27.58 | 31.86% |
| Buy | $59.1B | 242.42% | NA | -12.96% |
About Transcode Therapeutics Inc
Key Management of Transcode Therapeutics Inc
Important FAQs about investing in RNAZ Stock from India :
What is Transcode Therapeutics share price today?
Transcode Therapeutics share price today is $10.12 as on . Transcode Therapeutics share today touched a day high of $10.14 and a low of $10.12.
What is the 52 week high and 52 week low for Transcode Therapeutics share?
Transcode Therapeutics share touched a 52 week high of $739.20 and a 52 week low of $6.15. Transcode Therapeutics stock price today i.e. is trending at $10.12, lower by 98.63% versus the 52 week high.
How to invest in Transcode Therapeutics Stock (RNAZ) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Transcode Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Transcode Therapeutics Shares that will get you 0.1482 shares as per Transcode Therapeutics share price of $10.12 per share as on August 28, 2025 at 11:34 pm IST.
What is the minimum amount required to buy Transcode Therapeutics Stock (RNAZ) from India?
Indian investors can start investing in Transcode Therapeutics (RNAZ) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Transcode Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 28, 2025).
Based on Transcode Therapeutics share’s latest price of $10.12 as on August 28, 2025 at 11:34 pm IST, you will get 0.9881 shares of Transcode Therapeutics. Learn more about
fractional shares .
What are the returns that Transcode Therapeutics has given to Indian investors in the last 5 years?
Transcode Therapeutics stock has given -100.0% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Cai International Inc$38.30
+0.21%
- Invesco Bs 2033 Hycb Etf
$25.36
+0.0%
- Alps Clean Energy Etf
$29.62
+0.07%
- First Trust Exchange-traded
$22.72
+0.09%
Gamesquare Holdings Inc$0.80
+1.27%
- Beehive Etf
$24.65
+0.2%
- Avidia Bancorp Inc
$15.30
+0.26%
Yieldmax Googl Option Income Strategy Etf$13.42
+0.98%
Monopar Therapeutics Inc$36.39
+4.54%